Icariside II attenuates renal fibrosis through mTOR signaling modulation: an integrated approach combining network pharmacology, molecular dynamics, and in vitro validation
ICA-II demonstrates anti-fibrotic effects through a multi-target, multi-pathway regulatory network. Its beneficial role in RF may involve direct inhibition of mTOR activity, thereby attenuating excessive extracellular matrix (ECM) accumulation. These findings provide a theoretical and experimental basis for ICA-II as a promising candidate for the treatment of RF.
Authors
- Zhongcheng Xin (ORCID: https://orcid.org/0000-0002-0361-2737)
- Changli Wu (ORCID: https://orcid.org/0009-0007-7215-7866)
- Pingyun Ding
- Yuhong Feng (ORCID: https://orcid.org/0000-0002-6138-5229)
- Jiancheng Pan (ORCID: https://orcid.org/0000-0002-7703-7667)
- Wenjie Tian (ORCID: https://orcid.org/0000-0002-4328-0255)
- Ge Gao (ORCID: https://orcid.org/0009-0003-3767-237X)
- Yongjiao Yang (ORCID: https://orcid.org/0000-0003-0156-6164)
Institutions
- Tianjin Central Hospital of Gynecology Obstetrics (CN)
- Second Hospital of Tianjin Medical University (CN)
- Second Affiliated Hospital of Jilin University (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Translational Andrology and Urology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/tau-2025-395
- Primary Topic
- Medicinal Plant Pharmacodynamics Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00